323 related articles for article (PubMed ID: 31642415)
1. Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches.
Malliappan SP; Kandasamy P; Chidambaram S; Venkatasubbu D; Perumal SK; Sugumaran A
Anticancer Agents Med Chem; 2020; 20(11):1300-1310. PubMed ID: 31642415
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers for diagnosis and targeting of breast cancer.
Sharma A; Jain N; Sareen R
Biomed Res Int; 2013; 2013():960821. PubMed ID: 23865076
[TBL] [Abstract][Full Text] [Related]
4. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
Kumar L; Baldi A; Verma S; Utreja P
Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
[TBL] [Abstract][Full Text] [Related]
5. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites.
Attia MF; Anton N; Wallyn J; Omran Z; Vandamme TF
J Pharm Pharmacol; 2019 Aug; 71(8):1185-1198. PubMed ID: 31049986
[TBL] [Abstract][Full Text] [Related]
6. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
7. Nanocarrier based approaches for targeting breast cancer stem cells.
Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK; Karri VVSR
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):885-898. PubMed ID: 28826237
[TBL] [Abstract][Full Text] [Related]
8. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
9. Passive and active tumour targeting with nanocarriers.
Hirsjärvi S; Passirani C; Benoit JP
Curr Drug Discov Technol; 2011 Sep; 8(3):188-96. PubMed ID: 21513482
[TBL] [Abstract][Full Text] [Related]
10. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
[TBL] [Abstract][Full Text] [Related]
11. Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex beyond Tumor-Targeted Delivery.
Yongvongsoontorn N; Chung JE; Gao SJ; Bae KH; Yamashita A; Tan MH; Ying JY; Kurisawa M
ACS Nano; 2019 Jul; 13(7):7591-7602. PubMed ID: 31262169
[TBL] [Abstract][Full Text] [Related]
12. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
13. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
14. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL
Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402
[TBL] [Abstract][Full Text] [Related]
15. Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects.
Allahverdiyev AM; Parlar E; Dinparvar S; Bagirova M; Abamor EŞ
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S755-S762. PubMed ID: 30260234
[TBL] [Abstract][Full Text] [Related]
16. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
18. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
Bhatia R; Sharma A; Narang RK; Rawal RK
Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
[TBL] [Abstract][Full Text] [Related]
19. A robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transporters.
Kumar P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2018 Nov; 171():437-444. PubMed ID: 30075419
[TBL] [Abstract][Full Text] [Related]
20. Distinction Between Active and Passive Targeting of Nanoparticles Dictate Their Overall Therapeutic Efficacy.
Clemons TD; Singh R; Sorolla A; Chaudhari N; Hubbard A; Iyer KS
Langmuir; 2018 Dec; 34(50):15343-15349. PubMed ID: 30441895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]